Cost-effectiveness and Value of Information Analysis of Multiple Frequency Bioimpedance Devices for Fluid Management in People with Chronic Kidney Disease Having Dialysis

Overview

Journal Cost Eff Resour Alloc

Publisher Biomed Central

Date 2021 Apr 27

PMID 33902602

Authors

Elisabet Jacobsen

Moira Cruickshank

David Cooper

Angharad Marks

Miriam Brazzelli

Graham Scotland

Affiliations

Soon will be listed here.

Abstract

Background: Among people with chronic kidney disease (CKD) on dialysis, sub-optimal fluid management has been linked with hospitalisation, cardiovascular complications and death. This study assessed the cost-effectiveness using multiple-frequency bioimpedance guided fluid management versus standard fluid management based on clinical judgment.

Methods: A Markov model was developed to compare expected costs, outcomes and quality adjusted life years of the alternative management strategies. The relative effectiveness of the bioimpedance guided approach was informed by a systematic review of clinical trials, and focussed reviews were conducted to identify baseline event rates, costs and health state utility values for application in the model. The model was analysed probabilistically and a value of information (VOI) analysis was conducted to inform the value of conducting further research to reduce current uncertainties in the evidence base.

Results: For the base-case analysis, the incremental cost-effectiveness ratio (ICER) for bioimpedance guided fluid management versus standard management was £16,536 per QALY gained. There was a 59% chance of the ICER being below £20,000 per QALY. Form the VOI analysis, the theoretical upper bound on the value of further research was £53 million. The value of further research was highest for parameters relating to the relative effectiveness of bioimpedance guided management on final health outcomes.

Conclusions: Multiple frequency bioimpedance testing may offer a cost-effective approach to improve fluid management in patients with CKD on dialysis, but further research would be of value to reduce the current uncertainties.

References

Tsai Y, Chiu Y, Tsai J, Kuo H, Hung C, Hwang S . Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD. Clin J Am Soc Nephrol. 2014; 10(1):39-46. PMC: 4284411. DOI: 10.2215/CJN.03610414. View

MacNeill S, Casula A, Shaw C, Castledine C . UK Renal Registry 18th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2014: National and Centre-specific Analyses. Nephron. 2016; 132 Suppl 1:41-68. DOI: 10.1159/000444816. View

Treharne C, Liu F, Arici M, Crowe L, Farooqui U . Peritoneal dialysis and in-centre haemodialysis: a cost-utility analysis from a UK payer perspective. Appl Health Econ Health Policy. 2014; 12(4):409-20. PMC: 4110409. DOI: 10.1007/s40258-014-0108-7. View

Hur E, Usta M, Toz H, Asci G, Wabel P, Kahvecioglu S . Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis. 2013; 61(6):957-65. DOI: 10.1053/j.ajkd.2012.12.017. View

Onofriescu M, Mardare N, Segall L, Voroneanu L, Cusai C, Hogas S . Randomized trial of bioelectrical impedance analysis versus clinical criteria for guiding ultrafiltration in hemodialysis patients: effects on blood pressure, hydration status, and arterial stiffness. Int Urol Nephrol. 2011; 44(2):583-91. DOI: 10.1007/s11255-011-0022-y. View

Grima D, Bernard L, Dunn E, McFarlane P, Mendelssohn D . Cost-effectiveness analysis of therapies for chronic kidney disease patients on dialysis: a case for excluding dialysis costs. Pharmacoeconomics. 2012; 30(11):981-9. DOI: 10.2165/11599390-000000000-00000. View

Badve S, Palmer S, Strippoli G, Roberts M, Teixeira-Pinto A, Boudville N . The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2016; 68(4):554-563. DOI: 10.1053/j.ajkd.2016.03.418. View

Bozzetto S, Piccoli A, Montini G . Bioelectrical impedance vector analysis to evaluate relative hydration status. Pediatr Nephrol. 2009; 25(2):329-34. DOI: 10.1007/s00467-009-1326-3. View

Ara R, Brazier J . Populating an economic model with health state utility values: moving toward better practice. Value Health. 2010; 13(5):509-18. DOI: 10.1111/j.1524-4733.2010.00700.x. View

10.

Hoyle M, Henley W . Improved curve fits to summary survival data: application to economic evaluation of health technologies. BMC Med Res Methodol. 2011; 11:139. PMC: 3198983. DOI: 10.1186/1471-2288-11-139. View

11.

Verbeke F, Van Biesen W, Honkanen E, Wikstrom B, Jensen P, Krzesinski J . Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol. 2010; 6(1):153-9. PMC: 3022237. DOI: 10.2215/CJN.05120610. View

12.

Lambers Heerspink H, Ninomiya T, Zoungas S, de Zeeuw D, Grobbee D, Jardine M . Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2009; 373(9668):1009-15. PMC: 2659734. DOI: 10.1016/S0140-6736(09)60212-9. View

13.

Ozkahya M, Ok E, Toz H, Asci G, Duman S, Basci A . Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant. 2006; 21(12):3506-13. DOI: 10.1093/ndt/gfl487. View

14.

Chamney P, Wabel P, Moissl U, Muller M, Bosy-Westphal A, Korth O . A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr. 2007; 85(1):80-9. DOI: 10.1093/ajcn/85.1.80. View

15.

Scotland G, Cruickshank M, Jacobsen E, Cooper D, Fraser C, Shimonovich M . Multiple-frequency bioimpedance devices for fluid management in people with chronic kidney disease receiving dialysis: a systematic review and economic evaluation. Health Technol Assess. 2018; 22(1):1-138. PMC: 5776406. DOI: 10.3310/hta22010. View

16.

Huan-Sheng C, Yeong-Chang C, Ming-Hsing H, Fan-Lieh T, Chu-Cheng L, Tsai-Kun W . Application of bioimpedance spectroscopy in Asian dialysis patients (ABISAD-III): a randomized controlled trial for clinical outcomes. Int Urol Nephrol. 2016; 48(11):1897-1909. DOI: 10.1007/s11255-016-1415-8. View

17.

Karim A, Farrugia D, Cheshire J, Mahboob S, Begaj I, Ray D . Recipient age and risk for mortality after kidney transplantation in England. Transplantation. 2013; 97(8):832-8. DOI: 10.1097/01.TP.0000438026.03958.7b. View

18.

Tonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D . Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011; 11(10):2093-109. DOI: 10.1111/j.1600-6143.2011.03686.x. View

19.

Rayner H, Pisoni R, Bommer J, Canaud B, Hecking E, Locatelli F . Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2003; 19(1):108-20. DOI: 10.1093/ndt/gfg483. View

20.

Chazot C, Wabel P, Chamney P, Moissl U, Wieskotten S, Wizemann V . Importance of normohydration for the long-term survival of haemodialysis patients. Nephrol Dial Transplant. 2012; 27(6):2404-10. DOI: 10.1093/ndt/gfr678. View